Zhiwen Yang
Papers
1
Total Citations
2
H-Index
1
About
Zhiwen Yang is a surgical oncologist whose research focuses on advancing the treatment of head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His most cited work provides critical clinical evidence on the efficacy of transoral robotic surgery (TORS), demonstrating that this minimally invasive approach offers superior prognostic outcomes compared to traditional treatment methods. Yang’s research specifically highlights that patients with T1-T2 stage tumors achieve significant survival benefits from TORS, while also confirming that HPV-positive OPSCC patients experience markedly better prognoses than their HPV-negative counterparts. Although his seminal paper has garnered 2 citations, its clinical relevance is substantial, as it directly informs surgical decision-making and patient stratification in oncologic practice. By systematically comparing robotic surgery outcomes with conventional therapies, Yang has contributed to the growing body of evidence supporting TORS as a standard-of-care option for early-stage OPSCC. His work underscores the importance of both technological innovation and biomarker status in optimizing treatment protocols, offering practical guidance for surgeons and oncologists seeking to improve survival rates and quality of life for patients battling this challenging malignancy.
Research Focus
Key Achievements
Top Papers
- 1